InvestorsHub Logo
Followers 65
Posts 23855
Boards Moderated 0
Alias Born 11/23/2016

Re: Doc328 post# 454168

Saturday, 03/16/2024 3:22:36 AM

Saturday, March 16, 2024 3:22:36 AM

Post# of 461389
Discovery if granted and giving access to eg. the SAP is the only way to potentially make a case that the company’s statements about the AVATAR trial and endpoints were false or the company omitted material information.

I will be looking for the wording of the company’s defence lawyers motion to dismiss.

If denied, then what will the amended and consolidated complaint cause say based on information gained during discovery?

Either way that should help to dismiss or confirm investor suspicions of the Anavex approach to clinical trials and their readouts.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News